SLC36A4

Across TCGA pan-cancer cohorts, SLC36A4 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SLC36A4’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where SLC36A4 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types SLC36A4 is over-expressed in tumor.

HNSC and LUAD are the cancer types where SLC36A4 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC36A4 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.665	.036	6	view →
LUAD	Male	All	+0.373	.010	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

SLC36A4–HNSC

Open the HNSC breakdown →